Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More - Xconomy
    CA, was acquired by Bristol-Myers ... will feed NGM’s metabolic drug ... have the option to buy up to 585,000 ... a replacement peptide for ...
    02/26/2015 - 2:28 pm | View Link
  • Stocks to Watch: DISH, Armstrong World Industries, Darden ... - Wall Street Journal
    Bristol-Myers Squibb Co. ...  said Monday it agreed to buy the ... its late-stage diabetes treatment to both ... The Food and Drug ...
    02/23/2015 - 9:42 am | View Link
  • More
  • How To Snag A Drug R&D Partner: 3 Takeaways From Merck's Latest Deal
    It’s been a week of high-profile acquisitions. We saw Bristol-Myers Squibb snap up Flexus Biosciences for its immunotherapy programs. Shire bought Meritage Pharma. After the Allergan flop, Valeant finally got Salix Pharma to go steady, and Ipsen shelled out 6 million euros to buy U.K.-based biotech Canbex. But arguably more attention was placed on one $450 million collaboration than on the ...
    02/27/2015 - 6:07 pm | View Link
  • BUZZ-U.S. STOCKS ON THE MOVE-Biocept, Rigel, Spectrum
    U.S. stocks edged lower in morning trading Monday amid weakness in oil prices, after a conditional agreement by euro zone finance ministers to extend Greece's bailout sent the Dow and S&P to record levels ...
    02/23/2015 - 1:12 pm | View Link
  • 1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
    1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
    02/13/2015 - 8:37 am | View Link
  • Bloomberg the Company
    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
    02/12/2015 - 11:48 pm | View Link
  • More
  • The Best Dividend-Paying Healthcare Stocks
    No. 3 Bristol ... ofthe diabetes business sale and no longer have to back its impact out to see that the company is growing, investors' attention should shift back to the company's product lineup, which includes the top-selling cancer drug Yervoy, the ...
    03/29/2015 - 6:08 am | View Link
  • 4 Pharmaceutical Stocks to Buy for Outperformance in 2015
    Many analysts are bullish on the drug and look for more updates and launch information to be forthcoming soon. With a host of additional pipeline candidates, the stock makes good sense at current levels. Bristol-Myers investors are paid a 2.2% dividend.
    03/24/2015 - 12:12 am | View Link
  • Lexicon Pharmaceuticals
    The company has two late stage candidates under development for carcinoid syndrome and diabetes ... Big Pharma may merely buy rights to the drug of interest. Some of the potential suitors that may line up in my opinion include Bristol-Myers Squibb ...
    03/20/2015 - 3:43 am | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 9:10 pm | View Link
  • AstraZeneca to buy Bristol stake in diabetes venture for up to $4.1 bln
    Speculation that such a deal might be on the cards was fuelled last month after Bristol decided to exit diabetes drug research. The Bristol-AstraZeneca diabetes joint venture includes the oral medicines Onglyza, Kombiglyze and Forxiga, as well as the ...
    12/18/2013 - 8:18 pm | View Link
  • More
  • Diabetes savings care center buy supplies get rewards ...
    *CVS/pharmacy reserves the right to modify the terms of the program. **American Diabetes Association. †Double ExtraBucks® Rewards offer applies only to select ...
    03/29/2015 - 8:58 am | View Website
  • Adult Type 2 Diabetes Medication |
    Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
    03/29/2015 - 1:34 am | View Website
  • FDA Accepts New Drug Application for Investigational ...
    Dapagliflozin is a new drug in development for the treatment of type 2 diabetes. Dapagliflozin information includes news, clinical trial results and side effects.
    03/28/2015 - 12:09 am | View Website
  • AstraZeneca to buy Bristol-Myers Squibb's stake in ...
    AstraZeneca announced Thursday an agreement to acquire Bristol-Myers Squibb's stake in the companies' diabetes joint venture for potentially as much as $4.3 billion ...
    03/27/2015 - 8:06 pm | View Website
  • Bristol-Myers Squibb: Press Releases
    Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over ...
    03/26/2015 - 2:23 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News